Ruri Kikura‐Hanajiri

Author

National Institute of Health Sciences ORCID

Also Known As

R KIKURAHANAJIRI, R. Kikura-Hanajiri, Rui Kikura-Hanajiri, Ruri KIKURA-HANAJIRI, Ruri Kikura-Hanajiri, Ruri Kikura‐Hanajiri

143

Publications

Citations

H-Index

Concepts

All Affiliations

National Institute of Health Sciences National Institute of Health Sciences Chiba University

About

Ruri Kikura‐Hanajiri is an author at National Institute of Health Sciences specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	48	2.5K
2	Natural Sciences	10	10	487
3	Engineering	4	4	120
4	Health Sciences	3	3	194
5	Education	1	1	10

Ruri Kikura‐Hanajiri

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products Nahoko Uchiyama, Ruri Kikura‐Hanajiri, Jun Ogata, Forensic Science International Cannabis UseMedicinal ChemistryDrug AnalysisNatural Product SynthesisChemical Analysis	2010	246
Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase Polymorphism Emiko Sugiyama, Nahoko Kaniwa, Su-Ryang Kim, Journal of Clinical Oncology	2006	187
Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product Nahoko Uchiyama, Ruri Kikura‐Hanajiri, Nobuo Kawahara, Chemical and Pharmaceutical Bulletin	2009	172
Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products Nahoko Uchiyama, Satoru Matsuda, Maiko Kawamura, Forensic Toxicology Cannabis UseMolecular PharmacologyMedicinal ChemistryIllegal ProductsThiophene Derivative α-Pvt	2013	162
URB-754: A new class of designer drug and 12 synthetic cannabinoids detected in illegal products Nahoko Uchiyama, Maiko Kawamura, Ruri Kikura‐Hanajiri, Forensic Science International Cannabis UseSubstance AbuseMedicinal ChemistryDrug DesignMedicine	2012	153
Identification of a cannabimimetic indole as a designer drug in a herbal product Nahoko Uchiyama, Ruri Kikura‐Hanajiri, Nobuo Kawahara, Forensic Toxicology MedicineHerbal ProductHerbal MedicineCannabimimetic IndoleHerb-drug Interaction	2009	141
Simultaneous analysis of mitragynine, 7-hydroxymitragynine, and other alkaloids in the psychotropic plant “kratom” (Mitragyna speciosa) by LC-ESI-MS Ruri Kikura‐Hanajiri, Maiko Kawamura, Takuro Maruyama, Forensic Toxicology Herbal MedicineSimultaneous AnalysisPhytopharmacologyPhytochemicalOther Alkaloids	2009	123
Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan Ruri Kikura‐Hanajiri, Maiko Kawamura Nahoko Uchiyama, Yukihiro Goda Drug Testing and Analysis	2013	122
Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products Nahoko Uchiyama, Maiko Kawamura, Ruri Kikura‐Hanajiri, Forensic Toxicology Cannabis UseMedicinal ChemistryDrug AnalysisPsychoactive DrugNew-type Synthetic Cannabinoids	2012	122
Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products Nahoko Uchiyama, Maiko Kawamura, Ruri Kikura‐Hanajiri, Forensic Toxicology Pharmaceutical ScienceDerivative (Chemistry)BiochemistryMedicineDesigner Drugs	2010	120

Page 1